New study identifies unique type of microglia associated with stroke in the I/R injured brain

Medical researchers have identified a new type of microglia associated with stroke in the ischemia/reperfusion (I/R) injured brain. A research team, affiliated with UNIST has identified a new type of microglia associated with stroke in the ischemia/reperfusion (I/R) injured brain. This breakthrough has been led by Professor Sung Ho Park and his research team in the Department of Biological Sciences at UNIST, in collaboration with a research team, led by Professor Goo Taeg Oh from Ewha Womans University. Microglia, the primary immune cells in the central nervous system (CNS), are known to eliminate unwanted germs and debris and remove dying neurons. In this study, the research team classified a new type of microglia with enhanced antioxidant function and markers similar to those of disease-associated microglia (DAM), designated them as stroke-associated microglia (SAM). Through animal experiments, the research team demonstrated that the presence of the typical antioxidant gene, Peroxiredoxin-1 (Prdx1), protects against acute I/R injury and is required for SAM activation and the consequent reduction of microglial cell death and inflammatory responses. In addition, after performing transient middle cerebral artery occlusion (tMCAO) surgery to induce ischemic stroke in mice, the research team found that Prdx1−/− mice were more severely injured by acute I/R injury, as confirmed by TTC staining, neurological deficit scores, motor tests, and the survival rate, indicating that Prdx1 has a protective function. "In this study, we have, for the first time, identified a specialized and distinctive type of microglia with enhanced antioxidant function in stroke mice," says Professor Park. "Prdx1-dependent SAM may be a potential biomarker and therapeutic target for protecting microglial function and treating brain I/R injury," He adds, "Although this new cluster will require further study, our findings provide a new perspective that Prdx1-mediated microglial heterogeneity is important in ischemic stroke." This study has been jointly participated by Wonhyo Lee, a doctoral researcher within the Department of Biological Sciences at UNIST and Sinai Kim, a doctoral researcher within the Department of Life Sciences at Ewha Womans University, as first authors. Their findings have been published in the August 2022 issue of Redox Biology. This study was carried out with the support of the National Research Foundation of Korea (NRF).
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.